Summary:
This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs across indications about how CMOs can better develop drugs patients want and derisk development by partnering with patient organizations. Specifically, the panelists address:
- Patient voice driving drug development forward
- Supporting health equity and patient access after approval
- Building genuine relationships and engaging early to get to the right patients at the right time and for better advocacy about your research
- Building a community of awareness and working with patients for support throughout the regulatory process
- Integrating the patient perspective in early
- Real world examples and their impacts
To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
Moderators
Joseph Palumbo, MD, MACPsych
EVP, CMO, Head of R&D
BioVie
Panelists
Laura Williams, MD, MPH
CMO
Ardelyx
Peter Schmidt, PhD
President and Chief Scientific Officer
Rho
Murray Abramson, MD, MPH
Chief Development Officer
Ascidian Therapeutics
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.